Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments
1 Sorbonne Paris-Cité, Paris Descartes University, Hepatogastroenterology and Gastrointestinal Oncology Department, Hôpital Européen Georges Pompidou, Paris, France; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France. Electronic address: ed.auclin@gmail.com.
2 Sorbonne University and Medical Oncology Department, Hôpital Saint Antoine, Paris, France.
3 Sorbonne Paris-Cité, Paris Descartes University, Hepatogastroenterology and Gastrointestinal Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
4 Oncology Multidisciplinary Research Group (GERCOR), France.
5 Department of Oncology, Hôpital Franco-Britanique, Levallois-Perret, France.
6 Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; Oncology Multidisciplinary Research Group (GERCOR), France. Electronic address: dvernerey@chu-besancon.fr.